Adverum Biotechnologies, Inc.
ADVM
$4.17
$0.000.00%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -82.99% | -74.46% | -57.02% | 30.21% | 30.88% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -63.66% | -28.56% | 10.07% | -10.21% | 4.33% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -82.05% | -73.03% | -55.07% | 27.76% | 29.28% |
|
|
|||||
| Total Current Assets | -82.05% | -73.03% | -55.07% | 27.76% | 29.28% |
| Net Property, Plant & Equipment | -37.22% | -31.02% | -31.75% | -9.18% | -7.83% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -61.49% | -65.86% | 9.27% | 3.62% | 164.92% |
| Total Assets | -69.11% | -62.10% | -48.60% | 15.45% | 19.11% |
|
|
|||||
| Total Accounts Payable | 490.47% | 140.65% | -4.11% | -16.19% | -2.76% |
| Total Accrued Expenses | 87.25% | 99.08% | 85.46% | 23.28% | -6.43% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -45.46% | -30.38% | -31.10% | 3.51% | 3.26% |
| Total Finance Division Other Current Liabilities | -26.65% | 30.42% | -6.97% | 36.20% | -30.48% |
| Total Other Current Liabilities | -26.65% | 30.42% | -6.97% | 36.20% | -30.48% |
| Total Current Liabilities | 61.80% | 39.60% | 16.45% | 14.60% | -4.16% |
|
|
|||||
| Total Current Liabilities | 61.80% | 39.60% | 16.45% | 14.60% | -4.16% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 32.78% | 34.03% | 34.31% | 25.48% | -3.98% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 41.87% | 35.70% | 30.04% | 23.24% | -4.04% |
|
|
|||||
| Common Stock & APIC | 1.85% | 1.04% | 1.19% | 13.39% | 13.53% |
| Retained Earnings | -22.28% | -20.78% | -17.93% | -13.99% | -10.50% |
| Treasury Stock & Other | -64.18% | 14.10% | 14.07% | 13.95% | 51.45% |
| Total Common Equity | -138.62% | -112.03% | -85.51% | 5.19% | 40.31% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -138.62% | -112.03% | -85.51% | 5.19% | 40.31% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -138.62% | -112.03% | -85.51% | 5.19% | 40.31% |
|
|
|||||